Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adaptimmune
Fierce Biotech
Cell therapy biotech keeps adapting, selling 4 programs for $55M
USWM plans on offering jobs to about half of Adaptimmune’s workforce. As of Dec. 31, 2024, the biotech had 506 employees.
Gabrielle Masson
Jul 28, 2025 10:52am
FDA signs off on first engineered cell therapy for a solid tumor
Aug 2, 2024 8:56am
Astellas' new CEO takes over a company in transition
Jun 13, 2023 8:50am
Astellas depreciates FibroGen's Evrenzo, nixes cell therapy deal
Apr 12, 2023 11:02am
